01—Abstract
Summary
Summary of the 10-Q filed August 6, 2010. Cited figures are marked; the original filing is the authoritative source.
CME Group Inc. reported solid financial results for the quarter and six months ended June 30, 2010.
Revenue increased significantly, driven by a substantial rise in clearing and transaction fees, which benefited from higher trading volumes across various product lines, particularly interest rate, foreign exchange, and energy products. Market data and information services also saw growth. Despite an increase in operating expenses, including a notable impairment charge related to Credit Market Analysis Limited (CMA) goodwill and trade name, the company maintained a strong operating margin.
Net income attributable to CME Group grew by 22%a for the quarter and 21% for the six-month period, leading to improved diluted earnings per common share. The company also demonstrated robust operating cash flow, with a significant increase compared to the prior year.
CME Group's balance sheet remained strong, with a healthy cash position and effective management of its debt facilities, though a new debt issuance for Index Services was noted. The company highlighted its ongoing share repurchase program and the strategic issuance of shares to BM&FBOVESPA as key capital allocation activities.
02—Key points
Key Highlights
- Total Revenues increased by 26% to $813.9 million for the quarter and 16% to $1,507.1 million for the six months ended June 30, 2010, driven primarily by a 27% rise in Clearing and Transaction Fees for the quarter and 19% for the six months.
- Clearing and Transaction Fees benefited from a 33% increase in total volume for the quarter and 23% for the six months, with significant growth in Interest Rate (38% quarter-over-quarter, 36% year-to-date), Foreign Exchange (82% quarter-over-quarter, 79% year-to-date), and Energy (29% quarter-over-quarter, 17% year-to-date) products.
- Net Income Attributable to CME Group increased by 22% to $270.7 million for the quarter and 21% to $510.9 million for the six months, resulting in a Diluted EPS of $4.11 and $7.73, respectively.
- Operating expenses increased by 20% for the quarter and 13% for the six months, largely due to a $20.5 million goodwill and trade name impairment charge for CMA, along with increased compensation and professional fees.
- Cash flows from operating activities saw a significant increase of 48% to $649.1 million for the first six months of 2010 compared to the same period in 2009, driven by higher trading volumes and profitability.
- A $612.5 million issuance of 4.40% fixed rate notes due 2018 by Index Services was completed in March 2010 to fund a distribution to Dow Jones.
- The company repurchased 46,697 shares of Class A common stock in the second quarter under its publicly announced share repurchase program.
03—One dollar
04—Financials
Financial Highlights
Figures from 10-QQ2 FY2010filed August 6, 2010Financial Statements
Q2 FY2010 against Q2 FY2009
| Line item | Q2 FY2010Q2 FY2009 | Change |
|---|---|---|
| Revenue | $813.90M$647.80M | +25.6% |
| Operating Expenses | $298.80M$249.00M | +20.0% |
| Operating Income | $515.10M$398.80M | +29.2% |
| Net Income | $270.70M$221.80M | +22.0% |
| EPS (Basic) | $0.83$0.67 | +23.7% |
| EPS (Diluted) | $0.82$0.67 | +23.4% |
| Shares Outstanding (Basic) | 327.91M331.64M | −1.1% |
| Shares Outstanding (Diluted) | 328.92M332.63M | −1.1% |
05—Questions
Frequently Asked Questions
What was the primary driver of CME Group's revenue growth in this period?
The primary driver of CME Group's revenue growth was a substantial increase in clearing and transaction fees, which rose by 27% for the quarter and 19% for the six-month period. This growth was fueled by higher trading volumes across key product lines, including interest rate, foreign exchange, and energy products.
How did the impairment charge affect the company's financial results?
The company recorded a $20.5 million impairment charge related to goodwill and trade name for its Credit Market Analysis Limited (CMA) operations. This charge contributed to an increase in operating expenses and impacted the effective tax rate due to the establishment of a full valuation allowance for the associated tax benefit. Despite this, overall revenue growth and strong operating performance helped to mitigate the impact on net income.
What is the outlook for CME Group's business in light of the Dodd-Frank Act?
The Dodd-Frank Act, signed into law in July 2010, is expected to bring significant changes to derivatives market oversight. While the Act presents opportunities, particularly in expanding over-the-counter (OTC) derivatives business through central clearing and trading on exchanges, there is uncertainty regarding the final rulemaking by regulators. Potential negative impacts could arise if regulations negatively affect customer trading activity or lead to a more restrictive, rules-based regulatory environment. CME Group aims to explore opportunities while navigating these regulatory changes.
How is CME Group managing its debt and capital resources?
CME Group maintained a strong liquidity position with $363.6 million in cash and cash equivalents as of June 30, 2010. The company has various debt instruments, including term loans and fixed-rate notes, and entered into a new $612.5 million note issuance in March 2010. It also has a significant revolving credit facility providing substantial borrowing capacity. The company is actively repurchasing its Class A common stock and has entered into strategic agreements, such as the one with BM&FBOVESPA, to manage its capital and ownership structure.
06—Continue